Clinical researchers are on a quest for breakthroughs in treatment and care. But the pressure is immense. They have to race against the clock to reach milestones to ensure continued funding, and rarely have time to keep track of which technologies are constantly being developed. Not only that, but faster and more reliable data means new treatments makes it to the patient bedside sooner. And this is exactly what inspired Mogens Kruhøffer to build a company to support clinical research groups.
It's very important that the instruments we have are robust and that they don't make errors and ruin the unique samples we receive.
Mogens Kruhøffer, founder and CEO, BioXpedia
Our intention is to not only look at a project itself at the time, but also where it is going and to use the right techniques from the start.
Mogens Kruhøffer, founder and CEO, BioXpedia
If you can look at protein interactions in QIAcuity, there are almost an infinite number of assays that you could develop for the instrument.
Mogens Kruhøffer, founder and CEO, BioXpedia
October 2021